Biopharmaceutical Process Analytical Technology Market is Expected to Reach $2.6 billion | MarketsandMarkets™

Chicago, May 31, 2024 (GLOBE NEWSWIRE) -- Biopharmaceutical Process Analytical Technology market in terms of revenue was estimated to be worth $1.2 billion in 2024 and is poised to reach $2.6 billion by 2029, growing at a CAGR of 16.0% from 2024 to 2029 according to a latest report published by MarketsandMarkets™.

Increased research and development investments from biopharmaceutical corporations are the main driving force behind the market's expansion. Over the last two decades, these companies have significantly boosted their R&D spending. By 2023, a wide range of medicines and vaccines are being researched and developed in various therapeutic areas, including COVID-19, cancer, diabetes, cardiovascular diseases, and Alzheimer's. The adoption of Process Analytical Technology (PAT) in R&D enables reliable measurements, providing a scientific understanding of drug engineering.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=95920337

Biopharmaceutical Process Analytical Technology Market Scope:

Report Coverage	Details
Market Revenue in 2024	$1.2 billion
Estimated Value by 2029	$2.6 billion
Growth Rate	Poised to grow at a CAGR of 16.0%
Market Size Available for	2022–2029
Forecast Period	2024–2029
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Type, Product Type, Mode, Application, and Region
Geographies Covered	North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Report Highlights	Updated financial information / product portfolio of players
Key Market Opportunity	Healthcare costs are on the rise in developing nations
Key Market Driver	Increasing demand for enhancing the quality of manufacturing processes

Furthermore, this technology reduces drug development timelines by offering predictive qualitative and quantitative models through advanced multicomponent PAT analyzers. This acceleration leads to faster drug approvals and quicker market entry. As a result, the increase in R&D investments from biopharmaceutical firms and government allocations in emerging nations drives the global utilization of sophisticated PAT instruments.

Based on the type of type, the global biopharmaceutical process analytical technology market has been segmented into—liquid chromatography/HPLC, GC Chromatography, mass spectrometry, real-time PCR/QPCR, NGS, NMR spectroscopy, raman spectroscopy, infrared spectroscopy, particle counters and imaging, dynamic light scattering and other technologies. In 2023, the liquid chromatography segment dominated the biopharmaceutical process analytical technology market with the highest share. The widespread use of this method for evaluating the quality of biopharmaceutical drugs significantly contributes to the expansion of this sector.

Based on product type, the global biopharmaceutical process analytical technology market has been segmented into— analyzers, sensors & probes, samples, and software. The analyzers segment holds a leading position in the biopharmaceutical process analytical technology market, and this trend is anticipated to persist in the foreseeable future. The primary driver of this segment's dominance is the continuous evolution of process analytical techniques, which contribute to improved operational efficiency and reduced process cycle times. Within this segment, various biopharmaceutical process analytical products including analyzers, sensors & probes, samplers, and software are utilized across both research and manufacturing processes to evaluate a wide range of quality attributes in samples.

Based on mode, the biopharmaceutical process analytical technology market, has been segmented into- on-line measurement, off-line measurement, at-line measurement, and in-line measurement. In 2024, online measurement segment hold the major share. The increased research and development spending by pharmaceutical and biopharmaceutical companies, coupled with rising government funding in developing countries, is propelling the global adoption of advanced Process Analytical Technology (PAT) instruments.

Based on application, the global biopharmaceutical process analytical technology market is broadly segmented into vaccines, cell and gene therapy, biosimilars & biologics, hormonal therapy and other applications. The biosimilars & biologics segment accounted for the largest share of the biopharmaceutical process analytical technology market in 2024. The surge in this market segment can primarily be attributed to the ease of vaccine utilization, their cost-effectiveness, and the increasing number of emerging startups and newcomers focused on drug development.

The biopharmaceutical process analytical technology market covers five key geographies—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America commanded the largest share of the market in 2023. The significant influence of North America's market originates primarily from its strong biopharmaceutical manufacturing industry, widespread adoption of cutting-edge technologies, and stringent FDA supervision of drug approval and safety protocols. Moreover, market growth in the region is propelled by increased investments in pharmaceutical and biotechnology research initiatives and a growing need for biologics.

Buy a Biopharmaceutical Process Analytical Technology Industry Report (255 Pages PDF with Insightful Charts, Tables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=95920337

Prominent Players of Biopharmaceutical Process Analytical Technology Market

• Thermo Fisher Scientific, Inc. (US)
• Danaher Corporation (US)
• Agilent Technologies, Inc. (US)
• Shimadzu Corporation (Japan)
• Waters Corporation (US)
• Bruker Corporation (US)
• Emerson Electric Co. (US)
• ABB Ltd. (Switzerland)
• PerkinElmer, Inc. (US)
• Mettler-Toledo International Inc. (US)
• Carl Zeiss AG (Germany)
• and Among others

This report has segmented the biopharmaceutical process analytical technology market based on type, product type, mode, application, and region.

Biopharmaceutical Process Analytical Technology Market, by Type

• Liquid Chromatography/HPLC
• GAS Chromatography (GC)
• Mass Spectrometry
• Real-Time PCR/QPCR
• NGS
• NMR Spectroscopy
• Raman Spectroscopy
• Infrared Spectroscopy
• Particle Counters and Imaging
• Differential Light Scattering
• Other Techniques 

Biopharmaceutical Process Analytical Technology Market, by Product Type

• Analyzers
• Sensor and Probes
• Samples
• Software

Biopharmaceutical Process Analytical Technology Market, by Mode

• On-line Measurement
• Off-line Measurement
• At-line Measurement 
• In-line Measurement

Biopharmaceutical Process Analytical Technology Market, by Application

• Vaccines 
• Cell and Gene Therapy
• Biosimilars & Biologics
• Hormonal Therapy
• Other Application

Biopharmaceutical Process Analytical Technology Market, by Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
• GCC Countries

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=95920337

Key Market Stakeholders:

• Process analytical technology manufacturers, suppliers, and providers
• Biopharmaceutical firms
• Contract research and manufacturing organizations
• Academic and private research institutions
• Research and Development (R&D) Companies
• Medical Research Laboratories
• Academic institutions and private research institutions
• Regulatory Agencies
• Quality Control and Assurance
• Contract Manufacturing Organizations (CMOs)
• Environmental and Safety Regulatory Bodies
• Public and Private Research Institutions
• Third-party Testing Laboratories

Report Objectives:

• To define, describe, and forecast the biopharmaceutical process analytical technology market based on type, product type, mode, application, and region
• To provide detailed information regarding the major factors influencing the growth potential of the global biopharmaceutical process analytical technology market (drivers, restraints, opportunities, challenges, and trends)
• To analyze the micro markets with respect to individual growth trends, future prospects, and contributions to the global biopharmaceutical process analytical technology market
• To analyze key growth opportunities in the global biopharmaceutical process analytical technology market for key stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of market segments and/or subsegments with respect to five major regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the RoE), Asia Pacific (Japan, China, India, and the RoAPAC), Latin America (Brazil, Mexico, and RoLATAM), and the Middle East & Africa
• To profile the key players in the global biopharmaceutical process analytical technology market and comprehensively analyze their market shares and core competencies
• To track and analyze the competitive developments undertaken in the global biopharmaceutical process analytical technology market, such as product launches; agreements; expansions; and mergers & acquisitions.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=95920337

Related Reports:

Biomarkers Market

Wound Care Market

Preimplantation Genetic Testing Market

Life Science Instrumentation Market

Next Generation Sequencing Market

Get access to the latest updates on Biopharmaceutical Process Analytical Technology Companies and Biopharmaceutical Process Analytical Technology Industry Growth

            About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com